01 / PSC Market Profile
PSC AN93 R&D- Medical: Other (Advanced Development) Federal Contracts
Product and Service Code AN93
Federal contract activity classified under R&D- Medical: Other (Advanced Development) across FY 2019–FY 2025. Net obligations include both new obligations and subsequent deobligations.
02 / Market Size
How large is the PSC AN93 federal market?
03 / Spending Trend
PSC AN93 contract spending by fiscal year
Annual obligations, activity, and participation across the same FY 2019–FY 2025 profile window.
Latest closed fiscal year$3.58M
FY 2025| Fiscal year | Obligations | Actions | Vendors | Customers | Change |
|---|---|---|---|---|---|
| FY 2019 | $23.28M | 45 | 29 | 4 | — |
| FY 2020 | $10.26M | 22 | 15 | 2 | −55.9% |
| FY 2021 | $9.07M | 39 | 24 | 3 | −11.7% |
| FY 2022 | $4.15M | 20 | 15 | 3 | −54.3% |
| FY 2023 | -$5.00M | 20 | 10 | 3 | −220.5% |
| FY 2024 | -$68.3K | 16 | 8 | 3 | +98.6% |
| FY 2025 | $3.58M | 6 | 4 | 2 | +5,348.5% |
04 / Top Federal Customers
Which federal agencies buy most in this industry?
Ranked by net obligations during FY 2019–FY 2025.
| Federal customer | Code | Obligations | Actions | Vendors | Market share |
|---|---|---|---|---|---|
| DEPT OF THE ARMY | 2100 | $32.93M | 127 | 34 | 72.7% |
| DEFENSE HEALTH AGENCY (DHA) | 97DH | $11.64M | 17 | 8 | 25.7% |
| DEFENSE THREAT REDUCTION AGENCY (DTRA) | 9761 | $424.8K | 2 | 2 | 0.9% |
| VETERANS AFFAIRS, DEPARTMENT OF | 3600 | $232.4K | 12 | 6 | 0.5% |
| DEPT OF THE AIR FORCE | 5700 | $43.4K | 9 | 1 | 0.1% |
| DEPARTMENTAL OFFICES | 1406 | $0 | 1 | 1 | 0.0% |
05 / Contracting Offices
Which contracting offices buy in PSC AN93?
Ranked by net obligations during FY 2019–FY 2025.
| Office | Code | Agency | Obligations | Actions | Vendors | Market share |
|---|---|---|---|---|---|---|
| W4PZ USA MED RSCH ACQUIS ACT | W81XWH | DEPT OF THE ARMY | $32.49M | 121 | 32 | 71.8% |
| ARMY MED RES ACQ ACTIVITY | HT9425 | DEFENSE HEALTH AGENCY (DHA) | $11.64M | 17 | 8 | 25.7% |
| W6QK ACC-APG NATICK | W911QY | DEPT OF THE ARMY | $441.0K | 6 | 2 | 1.0% |
| DEFENSE THREAT REDUCTION AGENCY | HDTRA1 | DEFENSE THREAT REDUCTION AGENCY (DTRA) | $424.8K | 2 | 2 | 0.9% |
| 246-NETWORK CONTRACTING OFFICE 6 (36C246) | 36C246 | VETERANS AFFAIRS, DEPARTMENT OF | $195.0K | 1 | 1 | 0.4% |
| FA8650 USAF AFMC AFRL PZL AFRL/PZL | FA8650 | DEPT OF THE AIR FORCE | $43.4K | 9 | 1 | 0.1% |
| 262-NETWORK CONTRACT OFFICE 22 (36C262) | 36C262 | VETERANS AFFAIRS, DEPARTMENT OF | $30.3K | 1 | 1 | 0.1% |
| 248-NETWORK CONTRACT OFFICE 8 (36C248) | 36C248 | VETERANS AFFAIRS, DEPARTMENT OF | $25.3K | 1 | 1 | 0.1% |
| 252-NETWORK CONTRACT OFFICE 12 (36C252) | 36C252 | VETERANS AFFAIRS, DEPARTMENT OF | $9.2K | 8 | 2 | 0.0% |
| IBC ACQ SVCS DIRECTORATE (00004) | 140D04 | DEPARTMENTAL OFFICES | $0 | 1 | 1 | 0.0% |
06 / Top Vendors
Which contractors lead the PSC AN93 market?
| Vendor | Obligations | Actions | Customers | Market share | Latest activity |
|---|---|---|---|---|---|
| WESTAT, INC. | $15.36M | 17 | 2 | 33.9% | Aug 28, 2025 |
| EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | $5.72M | 14 | 2 | 12.6% | Jul 17, 2024 |
| MAXENTRIC TECHNOLOGIES, LLC | $4.77M | 4 | 2 | 10.5% | Jun 7, 2024 |
| CERAMEDIX HOLDING, LLC | $4.50M | 6 | 2 | 9.9% | Jul 10, 2023 |
| SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | $4.45M | 6 | 2 | 9.8% | Sep 9, 2025 |
| SANARIA INC. | $3.40M | 9 | 1 | 7.5% | Jun 3, 2024 |
| COOPER CONSULTING SERVICE | $2.65M | 9 | 2 | 5.8% | Jul 16, 2024 |
| CHRISTOPHER REEVE FOUNDATION, A NEW JERSEY NONPROFIT CORPORATION | $1.83M | 7 | 1 | 4.0% | Jun 24, 2022 |
| DALTON CHEMICAL LABORATORIES INC | $1.81M | 7 | 1 | 4.0% | Aug 2, 2022 |
| LAUNCHBAY LLC | $1.15M | 2 | 1 | 2.5% | Nov 5, 2020 |
07 / Industry Mix
What industries are purchased under PSC AN93?
| NAICS | Description | Obligations | Actions | Vendors | Share |
|---|---|---|---|---|---|
| 541715 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) | $18.09M | 41 | 7 | 40.0% |
| 541711 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY | $15.12M | 56 | 19 | 33.4% |
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $8.13M | 21 | 4 | 18.0% |
| 541712 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) | $3.65M | 42 | 11 | 8.1% |
| 541990 | ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES | $247.3K | 5 | 2 | 0.5% |
| 541940 | VETERINARY SERVICES | $30.3K | 1 | 1 | 0.1% |
| 334516 | ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING | $25.3K | 1 | 1 | 0.1% |
| 611310 | COLLEGES, UNIVERSITIES, AND PROFESSIONAL SCHOOLS | -$27.4K | 1 | 1 | -0.1% |
08 / Buying Pattern
How does the government buy in PSC AN93?
| Common action type | Obligations | Actions |
|---|---|---|
| DEFINITIVE CONTRACT | $43.92M | 149 |
| DELIVERY ORDER | $1.10M | 16 |
| PURCHASE ORDER | $250.6K | 3 |
09 / Recent Contract Awards
What was awarded most recently in PSC AN93?
| Award / PIID | Vendor | Signed date | Obligation | NAICS | Agency / office |
|---|---|---|---|---|---|
| W81XWH20C0116 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | Sep 9, 2025 | $0 | 541715 | DEFENSE HEALTH AGENCY (DHA)ARMY MED RES ACQ ACTIVITY |
| W81XWH15C0048 | WESTAT, INC. | Aug 28, 2025 | -$534.1K | 541711 | DEFENSE HEALTH AGENCY (DHA)ARMY MED RES ACQ ACTIVITY |
| 0030 | KBR WYLE SERVICES, LLC | Mar 24, 2025 | $8.6K | 541712 | DEPT OF THE AIR FORCEFA8650 USAF AFMC AFRL PZL AFRL/PZL |
| 0037 | KBR WYLE SERVICES, LLC | Mar 24, 2025 | $27.9K | 541712 | DEPT OF THE AIR FORCEFA8650 USAF AFMC AFRL PZL AFRL/PZL |
| W81XWH15C0048 | WESTAT, INC. | Feb 11, 2025 | $4.08M | 541711 | DEFENSE HEALTH AGENCY (DHA)ARMY MED RES ACQ ACTIVITY |
| W81XWH16C0020 | UNIVERSITY OF WASHINGTON | Jan 6, 2025 | $0 | 541712 | DEFENSE HEALTH AGENCY (DHA)ARMY MED RES ACQ ACTIVITY |
10 / Market Interpretation
How should contractors evaluate this market?
Start with the spending direction
Compare annual obligations with actions and vendor participation. Growth driven by only a few large actions represents a different opportunity from broad, recurring demand.
Follow the actual buyers
Move from federal customers to contracting offices. Offices reveal where acquisition responsibility and recurring purchasing activity are concentrated.
Measure accessible demand
Use competition, small-business participation, incumbent vendors, and PSC mix before treating the full $45.27M market as addressable.